The market for m-RNA synthesis services is anticipated to reach a value of US$ 6,438.6 million in 2023 and grow at a CAGR of 5.57% from 2023 to 2030.
Major players in the worldwide m-RNA synthesis service market are concentrating on organic growth methods including facility expansions, which are anticipated to fuel market growth over the forecast period. For example, TriLink BioTechnologies, a division of Maravai LifeSciences, expanded its contract development and manufacturing organisation (CDMO) capabilities in March 2021 with the introduction of its plasmid DNA (pDNA) manufacturing services. Maravai LifeSciences is a global provider of life science reagents and services to researchers and biotech entrepreneurs. Customers will benefit from the simplicity of a single-source messenger RNA (mRNA) solution produced with Current Good Manufacturing Practise (cGMP) capabilities, from plasmid synthesis through final release testing, thanks to TriLink's new plasmid services.
Key Companies in the Mrna Synthesis Service Industry:
1. Maravai LifeSciences: A life sciences business is Maravai LifeSciences Holdings Inc. It offers goods that help human disease research as well as the development of novel vaccines, diagnostics, and medicinal therapies. Created in 2014. United States headquarters. MyChem (Jan 2022), MockV Solutions (Mar 2020), and Glen Research (Jan 2018) are the most recent acquisitions.
2. Azenta US, Inc.: Azenta Inc. offers life sciences solutions globally, accelerating the release of significant discoveries and treatments.created in 1978. United States headquarters. The acquisition of the GENEWIZ Group is announced by Azenta Life Sciences.
3. Creative Biolabs: The top custom service supplier with considerable knowledge in several areas of engineering and antibody production is Creative Biolabs. Their service offering comprises the generation of monoclonal antibodies against mice and rats utilising hybridoma technology as well as against humans, monkeys, rabbits, chickens, dogs, llamas, and camels using various antibody library methods. Established in 2005. Greater New York Area, East Coast, and Northeastern US are the headquarters regions.
4. Becton, Dickinson And Company: Manufacturer of instrument systems and medical gadgets. A better outcome for both patients and doctors is made possible by the company's goods, which include surgical, diagnostic systems, patient monitoring, infusion, and other associated products. Built in 1897. United States headquarters. The most recent acquisitions are Cytognos (February 2022) and Parata Systems (June 2022).
5. Kaneka Corporation: Plastics, chemicals, and other items based on chemicals are all produced and sold by Kaneka Corp. Based on product category, the corporation divides itself into seven sectors. Margarine, shortening, bread yeast, and spices are sold in the foodstuffs category, which is the one that brings in the most money. Built in 1949. head office in Japan. From organic dairy farming to the creation and distribution of organic dairy products, Kaneka employs an integrated approach to the organic food industry.
6. Danaher: created in Founded 1969. Admin centre in the U.S. The founders of Danaher converted a real estate company into a manufacturing business with an industrial focus in 1984. Danaher today largely concentrates on producing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. This has been achieved through a succession of mergers, acquisitions, and divestitures. The business revealed plans to sell it’s environmental and applied solutions division in 2023, allowing it to only concentrate on the life sciences and diagnostics.
7. eTheRNA: Owner of a business using mRNA technology to deliver secure and effective mRNA treatments for the human immune system. Established in 2013. Head offices in Niel Belgium.
Definition: m-RNA synthesis is a processes by which m-RNA molecules are generated and are prepared for clinical applications such as vaccine development.
